SMTL ID : 4zzo.1

Human ERK2 in complex with an irreversible inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.63 Å

Oligo State

monomer

Ligands

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 3 residues within 4Å: Chain A: R.181, R.184, Y.223 6 PLIP interactions: 6 interactions with chain A Water bridges: A:R.181, A:R.181, A:R.184, A:Y.223 Salt bridges: A:R.181, A:R.184

1 x CQ3: N-[2-[[5-chloranyl-2-(oxan-4-ylamino)pyrimidin-4-yl]amino]phenyl]propanamide(Covalent)

CQ3.2: 18 residues within 4Å: Chain A: I.21, E.23, G.24, V.29, A.42, Q.95, D.96, L.97, M.98, E.99, T.100, D.101, K.104, S.143, N.144, L.146, C.156, D.157 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:I.21, A:V.29, A:V.29 Hydrogen bonds: A:M.98, A:M.98 Water bridges: A:A.25, A:S.143 Halogen bonds: A:Q.95

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ward, R.A. et al., Structure-Guided Design of Highly Selective and Potent Covalent Inhibitors of Erk1/2. J.Med.Chem. (2015)

Release Date

2015-05-27

Peptides

MITOGEN-ACTIVATED PROTEIN KINASE 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

MITOGEN-ACTIVATED PROTEIN KINASE 1

Related Entries With Identical Sequence